Development of innovative antimicrobials against pathogens resistant to antimicrobials
Today: 27/07/2026 · FUTURE · Forthcoming · Viewed
Funding agency: Horizon Europe
Call: HORIZON-HLTH-2027-01
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions | Deadline model: single-stage | Planned opening: 10/02/2027 | Model Grant Agreement: HORIZON Action Grant Budget-Based
The European Commission is seeking innovative solutions for the development of new antimicrobial agents to combat antibiotic resistance. The goal is to tackle diseases and reduce disease burden by supporting research and innovation in the health sector.
Budget total: 90000000.0 EUR | Budget per project: — EUR
Deadline: 13/04/2027 (260 days left) | Duration: — months | Funding intensity: 100.0% | Type: research
Eligibility: entity types: legal entity established in the European Union or an associated country, legal entity established in the United States of America; countries: —
#antimicrobials#pathogens resistant to antimicrobials#disease burden#health sector#research and innovation
Health
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| European Centre for Emerging Competencies and Technologies | 80% | ollama |
The opportunity's focus on 'innovative antimicrobials' in the Health domain is m…The opportunity's focus on 'innovative antimicrobials' in the Health domain is matched by the organization's expertise in robotics, AI and Big Data, and IoT technologies. The organization also has experience in supporting research and innovation projects, although its main areas of work (AgriTech Solutions, Augmented Reality/VR) are broader than the opportunity's topic. However, their 'Adult Education' domain is a strong match with the goal of providing training and certification in emerging technologies. |
Override |
| Novatex Solutions LTD | 0% | ollama |
The opportunity's topic of developing innovative antimicrobials against pathogen…The opportunity's topic of developing innovative antimicrobials against pathogens resistant to antimicrobials does not align with Novatex Solutions LTD's profile, which is focused on digital transformation, IoT, AI, robotics, and sustainability. There are no overlapping domain or technology tags between the two. [Weighted score: 0% AI judgment (65%) + 0% domain/technology tag overlap (35%) = 0%] |
Override |